PHIO icon

Phio Pharmaceuticals
PHIO

Overview Fund Trends Analyst Outlook Journalist POV

16 hedge funds and large institutions have $991K invested in Phio Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more ownership

Funds ownership: →

46% less capital invested

Capital invested by funds: $1.82M → $991K (-$832K)

61% less call options, than puts

Call options by funds: $13K | Put options by funds: $33K

Holders
16
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$13K
Puts
$33K
Net Calls
Net Calls Change

Top Buyers

1
+$86.8K
2
+$59.6K
3
+$19K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$17K
5
Renaissance Technologies
Renaissance Technologies
New York
+$10K

Top Sellers

1
-$83K
2
-$76.7K
3
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$285K
2
$213K
3
$129K
4
$107K
5
$50K
6
$45K
7
$40K
8
$37K
9
$29K
10
$19K
11
$17K
12
$10K
13
$7K
14
$2K
15
$1K
16
–
17
–